Dr. Gomberg-Maitland is the Director of Right Ventricular Failure, Heart Failure Preserved Ejection Fraction, and Cardio-Oncology Programs and the Co-Director of the Pulmonary Vascular Diseease Program and Clinical Trials Unit at Inova Fairfax Hospital. She earned her Bachelor’s degree from Yale, and her medical degree, with special distinction for research in cardiovascular medicine, from the Albert Einstein College of Medicine of Yeshiva University in Bronx, N.Y. She served her residency in internal medicine at New York Presbyterian Hospital, Weill-Cornell Medical Center, and a fellowship in cardiovascular diseases at the Mount Sinai Medical Center. During this fellowship she was also a visiting fellow in critical care medicine at New York Presbyterian Hospital/Weill-Cornell Medical Center and earned a Master’s degree in clinical epidemiology from the Harvard School of Public Health. Her research focus is in understanding the epidemiology of pulmonary hypertension and development of novel therapeutics and biomarkers. By designing and implementing the largest single center database, tracking all the patients in the pulmonary hypertension clinic, she identified new predictors of survival using simple tests (such as serum creatinine, and treadmill testing) and developed a new survival equation to better predict prognosis. She also implemented a new program of clinical trials testing novel drugs in PAH patients, successfully completing a phase IB trial in the USA with sorafenib, a drug approved for the treatment of renal and hepatocellular cancer a Phase I study of oral ranolazine. She is on multiple international trial steering committees, the lead on drug development at the Pulmonary Hypertension World Congress (JACC publication 2013), and on novel early development trials in early and late phase development in pulmonary hypertension.
She has over 120 publications in top tier medical journals including, CHEST, Circulation, Circulation Heart Failure, European Respiratory Journal, Journal of American College of Cardiology (JACC), JACC Heart Failure, JAMA-Internal Medicine, and the New England Journal of Medicine. She is the Past Chair of the Pulmonary Hypertension Council at the International Society of Heart and Lung Transplantation, Vice-Chair of the Education Committee at the International Society of Heart and Lung Transplantation, Section Editor at Journal of American College of Cardiology, and an Associate Editor at both CHEST and the European Respiratory Journal.